Close Menu

Progenika

The firm's Seqpro Lipo IS is the first approved NGS diagnostic assay for the disease, which affects one in 300 people.

NEW YORK (GenomeWeb) – Grifols has garnered a CE-IVD mark for ID Core XT, a bead array-based assay for molecular blood group typing, the company said this week.

Spanish genetic testing firm Progenika Biopharma will continue to pursue its business objectives after Barcelona-based plasma products manufacturer Grifols acquired a 60 percent stake in the firm for for €37 million ($48.4 million), according to its CEO.

Norwegian molecular diagnostics firm Genetic Analysis announced two new developments last week. The first was the appointment of Kari Stenerson, a former Axis-Shield marketing director, as its new CEO.

NEW YORK (GenomeWeb News) – Progenika this week said that its CLIA laboratory has received accreditation from the College of American Pathologists.
The Medford, Mass.-based firm provides blood group genotyping services to blood banks and hospitals in the US and Canada.

Progenika said last week that it has moved its US headquarters to Medford, Mass.

An agreement announced today gives Abyntek exclusive rights to provide Oragene DNA collection kits in Spain on an exclusive basis.

The deal will take Novartis into the blood genotyping market.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.